CUSIP: 817763105
Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,649,209
-
Share change
-
-6,827,242
-
Total reported value
-
$36,420,420
-
Put/Call ratio
-
9.6%
-
Price per share
-
$1.42
-
Number of holders
-
41
-
Value change
-
-$16,179,006
-
Number of buys
-
18
-
Number of sells
-
20
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2019
-
Previous quarter:
Q3 2018
Recent filing periods for CUSIP 817763105:
Institutional Holders of SESEN BIO INC - COM (SESN) as of Q4 2018
As of 31 Dec 2018,
SESEN BIO INC - COM (SESN) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,649,209 shares.
The largest 10 holders included
Consonance Capital Management LP, KINGDON CAPITAL MANAGEMENT, L.L.C., DRIEHAUS CAPITAL MANAGEMENT LLC, Vanguard Group Inc, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Castle Hook Partners LP, Schonfeld Strategic Advisors LLC, GEODE CAPITAL MANAGEMENT, LLC, and DRW Securities, LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.